Ischemic pre-conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways.
Cerebral gene expression is known to be significantly influenced by a sublethal ischemic event (pre-conditioning; PC) that induces tolerance to future damaging ischemic events. Small non-coding RNAs known as microRNAs (miRNAs) were recently shown to control the mRNA translation. We currently profiled cerebral miRNAs in the cerebral cortex of rats subjected to PC. The miRNAome reacted quickly and by 6 h following PC, levels of 51 miRNAs were altered (26 up- and 25 down-regulated; > 1.5-fold change). Twenty of these stayed at the altered level even at 3 days after PC. At least nine miRNAs showed > 5-fold change at one or more time points between 6 h to 3 days after PC compared with sham. Bioinformatics analysis showed 2007 common targets of the miRNAs that were up-regulated and 459 common targets of the miRNAs that were down-regulated after PC. Pathways analysis showed that MAP-kinase and Mammalian target of rapamycin (mTOR) signaling are the top two Kyoto Encyclopedia of Genes and Genomes pathways targeted by the up-regulated miRNAs, and Wnt and GnRH signaling are the top two Kyoto Encyclopedia of Genes and Genomes pathways targeted by the down-regulated miRNAs after PC. We hypothesize that alterations in miRNAs and their down-stream mRNAs of signaling pathways might play a role in the induction of ischemic tolerance.
Dharap
Ashutosh
A
Department of Neurological Surgery and Neuroscience Training Program, University of Wisconsin, Madison, Wisconsin 53792, USA.
Vemuganti
Raghu
R
D000818:Animals; D002540:Cerebral Cortex / Q000378:metabolism*; D019295:Computational Biology; D020869:Gene Expression Profiling / Q000379:methods; D005786:Gene Expression Regulation / Q000502:physiology*; D053263:Gene Regulatory Networks / Q000502:physiology*; D019194:Ischemic Preconditioning / Q000379:methods*; D008297:Male; D035683:MicroRNAs / Q000378:metabolism*; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods; D051381:Rats; D011918:Rats, Inbred SHR; D015398:Signal Transduction / Q000502:physiology*; D013997:Time Factors
D035683:MicroRNAs
Genes Dev. 2004 Dec 1;18(23):2893-904
15545625
Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):436-41
10618436
J Biol Chem. 2003 Aug 8;278(32):29655-60
12777372
Lancet Neurol. 2009 Nov;8(11):1056-72
19833297
Stroke. 1998 Sep;29(9):1937-50; discussion 1950-1
9731622
J Biol Chem. 2002 Oct 18;277(42):39728-38
12145288
Neurobiol Dis. 2006 Jan;21(1):18-28
16040250
Mol Cells. 2009 Dec 31;28(6):501-7
20047076
J Cell Sci. 2006 Jan 1;119(Pt 1):162-71
16371654
Bioinformatics. 2009 Aug 1;25(15):1991-3
19435746
J Cereb Blood Flow Metab. 2008 Jun;28(6):1104-13
18319730
J Cell Biol. 2001 Jan 8;152(1):87-96
11149923
Neurobiol Dis. 2010 Apr;38(1):17-26
20053374
Neurochem Int. 2006 Jul;49(2):127-35
16759752
Genome Res. 2009 Jan;19(1):92-105
18955434
PLoS Biol. 2004 Nov;2(11):e363
15502875
J Cereb Blood Flow Metab. 2009 Apr;29(4):675-87
19142192
Nucleic Acids Res. 2008 Jan;36(Database issue):D149-53
18158296
Science. 2002 Dec 6;298(5600):1911-2
12471242
Brain Res Mol Brain Res. 2002 Jun 30;103(1-2):106-15
12106696
Eur J Cardiothorac Surg. 1997 Aug;12(2):261-7
9288517
J Neurosci. 2002 Jul 15;22(14):5879-88
12122050
Stroke. 2007 Feb;38(2 Suppl):680-5
17261715
J Cereb Blood Flow Metab. 2010 Jan;30(1):92-101
19724284
Histol Histopathol. 2006 Jan;21(1):103-24
16267791
FASEB J. 2009 Jun;23(6):1625-37
19141537
J Neurochem. 2004 Apr;89(1):73-89
15030391
Science. 2006 Jul 21;313(5785):320-4
16809489
Cell. 2009 Jan 23;136(2):215-33
19167326
Cardiovasc Res. 2002 Aug 15;55(3):602-18
12160958
Lancet Neurol. 2009 Apr;8(4):398-412
19296922
Brain Res. 2007 Oct 26;1177:103-23
17916339
Cell. 2005 Jan 14;120(1):15-20
15652477
Stroke. 2008 Mar;39(3):959-66
18258830
Cancer Sci. 2010 Mar;101(3):700-6
20085589
Neurobiol Dis. 2009 Aug;35(2):264-9
19465127
Brain Res. 2004 Nov 19;1027(1-2):30-7
15494154
Bioinformatics. 2003 Jan 22;19(2):185-93
12538238
J Neurochem. 2009 Apr;109(1):287-94
19200341